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Summary: We report a transgenic line with highly pene-
trant cre recombinase activity in the somatotrope cells
of the anterior pituitary gland. Expression of the cre
transgene is under the control of the locus control
region of the human growth hormone gene cluster and
the rat growth hormone promoter. Cre recombinase ac-
tivity was assessed with two different lacZ reporter
genes that require excision of a floxed stop sequence
for expression: a chick b-actin promoter with the CMV
enhancer transgene and a ROSA26 knock-in. Cre activ-
ity is detectable in the developing pituitary after initia-
tion of Gh transcription and persists through adulthood
with high penetrance in Gh expressing cells and lower
penetrance in lactotropes, a cell type that shares a com-
mon origin with somatotropes. This Gh-cre transgenic
line is suitable for efficient, cell-specific deletion of
floxed regions of genomic DNA in differentiated somato-
tropes and a subset of lactotrope cells of the anterior
pituitary gland. genesis 47:55–60, 2009. VC 2008 Wiley-
Liss, Inc.
Key words: anterior pituitary gland; cell specific expression;
transgene; growth hormone; prolactin
INTRODUCTION
The pituitary gland is the central endocrine organ in ver-
tebrates. Through communication with the hypothala-
mus, the pituitary regulates a wide range of functions
including growth, fertility, lactation, stress response, ho-
meostasis, and metabolism. Disruption in normal pitui-
tary gland function may result in failed expansion of pi-
tuitary cell types, hormone deficiency, pituitary dwarf-
ism, or pituitary tumors (Cushman and Camper, 2001).
Somatotropes are cells responsible for growth hormone
(GH) production in the pituitary gland. GH is a key com-
ponent of the somatotropic axis, stimulating the produc-
tion of insulin-like growth factor-I (IGF-I) in the liver,
which in turn acts on numerous target organs to regulate
growth and a variety of other physiological processes
including hearing, vision, and glucose homeostasis
(Chandrashekar et al., 2007; Schneider et al., 2003;
Walenkamp and Wit, 2007).
Generation of pituitary cell-specific cre transgenic
lines has allowed for the study of particular pituitary cell
functions and cell lineage relationships (Bingham et al.,
2006; Charles et al., 2006, 2008; Cushman et al., 2000;
Jorgez et al., 2006; Luque et al., 2007; Naik et al., 2006;
Yin et al., 2008). We sought to generate a tool that
would be useful for studying the development and func-
tion of somatotropes, which represent approximately
40% of the cell population of the adult anterior lobe.
Cell specific gene targeting is invaluable for studying the
function of genes that have pleiotropic effects on devel-
opment, function, or carcinogenesis of vital organs caus-
ing embryonic lethality or complications due to multi-
organ effects. For example, a systemic knockout of the
growth hormone receptor (Ghr) produces cardiac and
pulmonary phenotypes, precluding assessment of func-
tions in other organs (Beyea et al., 2006; Egecioglu
et al., 2007). Here we present a transgenic cre line,
Tg(Gh-cre)SAC1, which expresses cre recombinase in
pituitary somatotropes, with limited expression in lacto-
tropes, and no detectable expression in other pituitary
cell types. We predict this to be a useful tool for targeted
gene ablation in committed somatotropes, and therefore
a valuable resource for the scientific community.
The Gh-cre transgenic construct contains 1.6 kb
of the human GH locus control region (LCR), 1.77 kb of
rat GH promoter, the coding sequences for a nuclear
localized cre, and b-actin polyadenylation sequences
(Fig. 1a). The rat GH promoter has produced strong
expression in transgenic mice (Akita et al., 1997; Beh-
ringer et al., 1988; Burton et al., 1991; Lira et al., 1988,
1993). The hGH LCR fragment (214.6 to 216.2 kb rela-
tive to the hGH promoter) contains two pituitary-spe-
cific DNase I-hypersensitive sites and is sufficient for
restricting expression to somatotropes and somatolacto-
tropes, for appropriately timed induction of hGH trans-
gene expression in mice starting at embryonic day
e15.5–e16.5, and for selective extinction of hGH in
mature lactotropes (Bennani-Baiti et al., 1998). The
human GH LCR improves the penetrance of rat GH
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promoter-driven transgene expression (Behringer et al.,
1988; Bennani-Baiti et al., 1998; Jin et al., 1999; Jones
et al., 1995; Nasonkin, 2002).
Twelve transgenic founder mice were initially sur-
veyed for transgene expression by mating with the chick
b-actin-LacZ cre reporter strain, known as Tg(flox-
lacZ)J7Sac (Cushman et al., 2000), and analysis of X-gal
staining in doubly transgenic progeny (Nasonkin, 2002).
Five of those lines exhibited robust staining in the adult
pituitary gland, and the best line, Tg(Gh-cre)SAC1, was
chosen for detailed analysis with two cre reporter
strains: chick b-actin-LacZ and Rosa26-LacZ, officially
known as B6.129S4-Gt(ROSA)26Sortm1Sor/J (Soriano,
1999).
Strong X-gal staining is evident in the anterior lobe of
pituitaries from mice carrying both the transgene Tg(Gh-
cre)SAC1 and the Rosa26-LacZ reporter allele, and there is
no significant background activity in mice with the
Rosa26-LacZ allele but no cre transgene (Fig. 1b). The
cell-specificity of cre-excision was assessed in mice car-
rying Tg(Gh-cre)SAC1 and the chick b-actin-LacZ cre re-
porter by immunohistochemical staining for pituitary
hormones and X-gal staining. Nearly all X-gal stained
cells also immunostained for GH, and the majority of GH
cells were X-gal stained (Fig. 1d). Despite this 1:1 corre-
spondence between X-gal staining and GH immunostain-
ing, a subset of the prolactin (PRL) expressing cells stain
for X-gal (Fig. 1e). These PRL, X-gal double positive cells
are likely to represent somatomammotropes, which
express both PRL and GH (Frawley and Boockfor, 1991).
To facilitate comparison of the Tg(Gh-cre)SAC1 trans-
gene with other cre strains, an analysis of cell specificity
and developmental activation was performed using the
popular Rosa26-LacZ allele. X-gal staining was observed
in the majority of GH immunopositive cell and a small
subset of the PRL immunopositive cells (Fig. 2a,b).
Quantitation of cre-mediated excision revealed 61 6
11% of the somatotropes are X-gal positive and 9 6 5%
of the lactotropes. These results are similar to those
obtained with the chick b-actin-LacZ reporter. X-gal
stained cells expressing the Rosa26-LacZ reporter have a
very small blue precipitate in a restricted cytosolic
region, while the entire nucleus turns blue using the
chick b-actin-LacZ reporter. This could result in underes-
timated penetrance with Rosa26-LacZ. No cre-mediated
excision is observed in adult thyrotropes, gonadotropes,
FIG. 1. Structure and function of Tg(Gh-cre)SAC1 transgene. A total of 1.6 kb of the human growth hormone locus control region was
cloned upstream of a 1.77 kb fragment containing the rat growth hormone promoter, the cre recombinase coding sequences, and the b-glo-
bin poly adenylation and terminator sequences (a). Pituitaries of adult mice doubly transgenic for Tg (Gh-cre)SAC1 and the Rosa26 floxed
stop lacZ reporter mouse strain stained blue with X-gal indicating cre-mediated recombination (b), whereas cre transgene negative mice
carrying the reporter have no X-gal staining (c). Tg(Gh-cre)SAC1 mice were mated to the cb-actin-CMV-floxed stop NLS-LacZ reporter and
tissues from doubly transgenic progeny stained with X-gal (Cushman et al., 2000). Nuclear localized blue staining, evidence of cre activity, is
detected in cells immunostained for GH (d) and PRL (e). Black arrows identify hormone-positive cells with cre activity, and white arrows
identify hormone-positive cells without cre activity.
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or corticotropes (Fig. 2c–e, respectively). Although it is
not uncommon for transgenes to exhibit variable activ-
ity, even within the same line, the majority of Tg(Gh-
cre)SAC1; Rosa-LacZ double transgenic mice exhibited
similar X-gal staining in the pituitary gland (17/18), sug-
gesting that Tg(Gh-cre)SAC1 is a reliable resource for dele-
tion in somatotropes. Gh expression is normally
detected in the mouse pituitary by embryonic day 15.5
(e15.5) (Japon et al., 1994). Tg(Gh-cre)SAC1 transgene ac-
tivity is not detectable at e14.5 (Fig. 2f), but it becomes
readily apparent between e15.5 and e18.5 (Fig. 2g).
Recombination in nonpituitary tissues was assessed in
Tg(Gh-cre)SAC1, Rosa-LacZ reporter mice. X-gal staining
was observed in the skin surrounding the forearm of
e16.5–e17.5 embryos. Low level X-gal staining
is detected in the kidney, ovary and testis of Tg(Gh-
cre)SAC1; Rosa-LacZ mice (see Fig. 3). The recombination
in nonpituitary tissues may not represent ectopic
expression because GH is expressed human skin, and
Gh transcripts are detectable in the brain and testis of
wild-type mice (Slominski et al., 2000), (http://www.
informatics.jax.org/searches/reference.cgi?46734). No
X-gal staining was observed in the adult liver, skeletal
muscle, adipose tissue, lung, spleen, or heart, and in one
occurrence minimal staining was observed in pancreas
(data not shown). No X-gal staining was seen in the pla-
centas of double transgenic embryos at e16.5. In addi-
tion, we detected no evidence of leaky cre activity in the
germline (data not shown).
Mouse strains that confer gene deletion in somato-
tropes have been developed using the promoter from
the rat GH releasing hormone receptor (Ghrhr) (Yin
et al., 2008) and the rat Gh promoter, similar to our strat-
egy, except without the human growth hormone locus
control region (Luque et al., 2007). In contrast to the
Ghrhr-cre strain, we find no evidence of cre-activity in
thyrotropes. The Tg(Gh-cre)SAC1 strain is the first to be
fully characterized for ectopic excision activity during
development and in adult tissues. Thus, the thorough
histological information we provide using a well-charac-
FIG. 2. Tg(Gh-cre)SAC1 is specific for the somatotrope, lactotrope lineages. Adult pituitaries from mice doubly transgenic for Tg(Gh-
cre)SAC1 and the Rosa26 lacZ reporter strain were stained with X-gal and antibodies specific for GH (a), prolactin (b), TSHb (c), LHb
(d), or POMC (e), developed with DAB to produce a brown color, and photographed at 3100 oil immersion magnification. Although
doubly transgenic embryos stained for X-gal show no blue staining at e14.5 (f), it is detected at e15.5 (g) when endogenous growth
hormone expression begins. Magnification bars (a, f) represent 10 lm (a–e, f, g, respectively).
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terized cre-reporter gene is an advantage of the Tg(Gh-
cre)SAC1 strain.
We expect that these transgenic mice will have many
uses. Permanently marked somatotropes could be dis-
persed and sorted for gene expression profiling
(Muzumdar et al., 2007) or used in intact tissue to study
the role of the interconnected cellular network in pro-
ducing sex-specific pulsatile patterns of GH secretion
(Bonnefont et al., 2005). Another potentially intriguing
application would be somatotrope-specific deletion of
Ghr to discover the role of GH feedback on the anterior
pituitary, given the many metabolic effects of systemic
Ghr deletion on skeletal and cardiac muscle function, ad-
iposity, liver function, carcinogenesis, and aging
(reviewed in Clark et al., 2006).
METHODS
Generation of Transgene Construct
The Gh-cre transgene construct was generated by PCR
amplification of 1.77 kb of sequence from the rat GH
(rGH) promoter (accession # X12967) using primers F
50-GGGTACCTCTAGAAGCTTAGTTTCTAGTAGG and R,
50-CCTGAGCAGTTTGGAATCTGG. The PCR product
was amplified using the Expand High Fidelity polymer-
ase mix (Roche, Indianapolis, IN) under the following
conditions: 958C for 2 min, followed by 5 cycles of 948C
for 45 s, 588C for 1 min and 728C for 2 min, then 25
cycles of 948C for 45 s, 618C for 1 min and 728C for
2 min, and a final 10 min extension at 728C. The rGH
FIG. 3. Minimal ectopic Tg(Gh-cre)SAC1 transgene expression. Very limited X-gal staining is detected in nonpituitary tissues such as the
skin surrounding the limbs and trunk of developing embryos (a). At e18.5, X-gal staining is appropriately restricted to the developing anterior
lobe (A) and is absent from the intermediate (I) and posterior (P) lobes (b). In adult tissues, X-gal staining is seen in the developing follicles of
some ovaries (c). Sporadic but very faint X-gal staining appears in the Leydig cells of the testes (d) and in the renal cortex (e). No staining is
detected in the adult liver (f). All magnification bars represent 50 lm.
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promoter was cloned upstream of the cassette contain-
ing the nuclear localized Cre and bactin-polyadenylation
sequences, in the pML78 plasmid at the XhoI site
(Meyers et al., 1998). To minimize the possibility of posi-
tion effect variegation of the transgene insertion site, a
1.6 kb BglII fragment of sequence from the human
growth hormone (hGH) locus control region (LCR) was
cloned upstream of the 1.77 kb rGH promoter (Bennani-
Baiti et al., 1998; Jin et al., 1999; Jones et al., 1995).
hGH LCR sequences (accession # AF039413) were
obtained by PCR amplification of human DNA using
hGH LCR primers F, 50-CGGGGTACCTCTAGAGATCT
TGTCTCAGAAAAACCC, (KpnI and XbaI cloning sites
underlined) and R, 50-GGGGTACCTCTAGAGATCTTGG
CCTAGGCCTCG with Expand High Fidelity polymerase
under the following conditions: 958C for 3 min, followed
by 5 cycles of 948C for 45 s, 608C for 1 min and 728C for
2 min, then 25 cycles of 948C for 40 s, 658C for 1 min
and 728C for 1 min 45 s, and a final extension at 728C for
10 min.
Generation, Maintenance,
and Characterization of Mice
The GH-cre transgene was injected into (C57BL/6J 3
SJL/J) F1 3 F1 zygotes, and the fertilized eggs were trans-
ferred into pseudopregnant foster mothers. Transgene
positive progeny were genotyped using PCR amplifica-
tion of genomic DNA for the presence of cre using the
following primers: 50-GCATAACCAGTGAAACAGCAT
TGCTG-30 and 50-GGACATGTTCAGGGATCGCCAGGCG-
30, under the following conditions: 948C for 3 min, fol-
lowed by 32 cycles of 948C for 30 s, 608C for 60 s and
728C for 90 s, and a final 10 min extension at 728C.
To determine the number of copies of the transgene
inserted into the genome, a Southern analysis was per-
formed using 10 lg of KpnI digested genomic tail DNA.
The copy number of Tg(GH-cre)SAC1 was estimated at
30–50 copies per haploid genome (data not shown).
Dissected pituitaries from adult progeny were assayed
for X-gal activity, as previously described (Brinkmeier
et al., 1998). The pituitaries of the doubly transgenic
progeny (n 5 8) were stained for X-gal activity as previ-
ously described (Cushman et al., 2000). Tissues were
embedded in paraffin and sectioned at 5-lm thickness.
Immunohistochemistry was performed for each of the
pituitary hormones as previously described (Kendall
et al., 1991).
Quantitation of cre-mediated excision in somatotropes
and lactotropes was accomplished using three doubly
transgenic mice positive for Tg(GH-cre)SAC1 and the
Rosa26-LacZ reporter. Three separate regions of the pitu-
itary were photographed after histochemical staining for
PRL or GH and X-gal. The average percentage of cells
positive for GH and X-gal was calculated by dividing the
total number of double positive cells by the total number
of GH positive cells. The same calculations were done
for PRL.
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